The Valliance Fund
Overview
The Valliance Fund is a hedge fund managed by Valliance Asset Management that uses a deep value and bottom-up investment approach in global liquid markets.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Beijing Safe Pharmaceutical Technology Co., Ltd. | Feb 2021 | IPO | Co-investor |
| Brii Biosciences | Jul 2021 | IPO | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is The Valliance Fund based?
The Valliance Fund is headquartered in Hong Kong, Hong Kong.
When was The Valliance Fund founded?
The Valliance Fund was founded in 2019.
How many portfolio companies does The Valliance Fund have?
The Valliance Fund has 2 portfolio companies in Caplight's dataset.
What are some companies in The Valliance Fund's portfolio?
Portfolio companies visible on Caplight include Beijing Safe Pharmaceutical Technology Co., Ltd., Brii Biosciences.
What was The Valliance Fund's most recent investment shown here?
The Valliance Fund's most recent investment in this portfolio sample was in Brii Biosciences in 2021.
What sectors does The Valliance Fund focus on?
The Valliance Fund focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does The Valliance Fund focus on?
Stage focus information for The Valliance Fund is not publicly available.
What is The Valliance Fund's AUM?
The Valliance Fund's assets under management are estimated between $13.0M and $150.0M.